From: Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
 | aMCI | naMCI | 95 % CI | p-value |
---|---|---|---|---|
Neuritic plaques | Â | Â | Â | Â |
 Frontal lobe | 1.5 (1.3) | 1.8 (1.3) | −1.0 to 0.6 | 0.55 |
 Temporal lobe | 1.5 (1.3) | 1.5 (1.3) | −0.7 to 0.9 | 0.88 |
 Parietal lobe | 1.6 (1.3) | 1.7 (1.7) | −1.0 to 0.7 | 0.76 |
 Hippocampus region | 0.7 (0.9) | 0.7 (0.8) | −0.53 to 0.53 | 1.00 |
 Entorhinal region | 1.3 (1.3) | 1.3 (1.0) | −0.8 to 0.8 | 0.97 |
Total (all areas; score out of 15) | 6.6 (5.7) | 1.2 (5.2) | −4.3 to 2.9 | 0.11 |
Neurofibrillary tangles | Â | Â | Â | Â |
 Braak NFT stage | IV (I-VI) | III (II-IV) | −0.22 to 0.95 | 0.22 |
 Frontal lobe | 0.4 (0.6) | 0.2 (0.3) | −0.06 to 0.60 | 0.11 |
 Temporal lobe | 1 (0.8) | 0.6 (0.7) | −0.04 to 0.91 | 0.07 |
 Parietal lobe | 0.4 (0.6) | 0.1 (0.2) | −0.02 to 0.60 | 0.07 |
 Hippocampus region | 2.2 (0.9) | 2.0 (0.9) | −0.30 to 0.80 | 0.36 |
 Entorhinal region | 2.6 (0.8) | 2.5 (0.8) | −0.38 to 0.60 | 0.66 |
Total (all areas; score out of 15) | 6.6 (2.8) | 5.2 (2.3) | −0.3 to3.1 | 0.11 |
Lewy type synucleinopathy | Â | Â | Â | Â |
 Olfactory bulb | 1.1 (1.6) | 1.5 (1.8) | −1.5 to 0.7 | 0.44 |
 Cingulate cortex | 0.6 (1.1) | 1.2 (1.6) | −1.4 to 0.1 | 0.11 |
 Frontal lobe | 0.2 (0.5) | 0.4 (0.8) | −0.55 to 0.22 | 0.39 |
 Temporal lobe | 0.2 (0.5) | 0.7 (1.0) | −0.9 to -0.3 | 0.04 |
 Parietal lobe | 0.2 (0.5) | 0.5 (0.7) | −0.64 to 0.12 | 0.17 |
 Amygdala | 0.9 (1.5) | 1.5 (1.8) | −1.5 to 0.5 | 0.29 |
 Transentorhinal cortex | 0.6 (1.1) | 1.1 (1.5) | −1.3 to 0.3 | 0.23 |
Total (all areas; score out of 15) | 6.6 (2.8) | 5.2 (2.3) | −0.3 to3.1 | 0.11 |
Other pathologies | Â | Â | Â | Â |
 Arg | 13 (37 %) | 4 (27 %) | n/a | 0.74 |
 CWMR | 22 (65 %) | 10 (67 %) | n/a | 0.89 |
 CAA | 16 (47 %) | 10 (67 %) | n/a | 0.21 |
 Brain neoplasms | 2 (6 %) | 0 | n/a | 1.0 |
 Acute infarcts | 6 (18 %) | 2 (13 %) | n/a | 1.0 |